Fluticasone propionate
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Fluticasone propionate
ATI class: Corticosteroid / Inhaled or intranasal corticosteroid
Action
- ATI/source-folder candidate for Fluticasone propionate; verify mechanism against the source table before validation.
Therapeutic use
- Review under Over-the-Counter Meds medication safety.
Nursing assessment
- Assess respiratory or allergy symptom pattern, inhaler or nasal technique, and concurrent steroid exposure.
- Monitor for oral white patches, hoarseness, nose irritation or bleeding, and signs of infection.
- Confirm it is not being used as a rescue medication for acute bronchospasm.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Oropharyngeal candidiasis with inhaled use
- Hoarseness
- Epistaxis or nasal irritation with intranasal use
- Adrenal suppression risk with high or prolonged exposure
Interactions
- Strong CYP3A4 inhibitors can increase systemic steroid exposure.
- Other corticosteroids increase cumulative steroid effects.
- Live vaccine precautions may apply with immunosuppressive steroid exposure.
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Untreated local infection in administration area
- Systemic infection risk or immunosuppression requires review.
- Acute bronchospasm requires rescue therapy, not controller steroid alone.
Client teaching
- Rinse mouth after inhaled use.
- Use consistently as prescribed; do not use as a quick-relief inhaler.
- Report white patches, worsening breathing, fever, or severe nosebleeds.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Steroid inhalers require mouth rinsing.
- Rescue inhaler comes before controller inhaler during acute symptoms.
- Worsening dyspnea or altered mental status requires escalation.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Suppresses inflammation and immune activity; systemic use affects glucose, infection risk, and adrenal response.
ATI medication precaution concept.
ATI medication adverse effect concept.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication nursing assessment concept.
ATI medication class concept.
ATI medication adverse effect concept.
ATI medication adverse effect concept.
ATI medication class concept.
ATI medication interaction concept.
ATI medication nursing assessment concept.